Inventor · disambiguated record
Xin Gan
Also filed as: GAN XIN
2 granted patents·8 pending applications·0 citations·filing 2018–2023
28Inventor score
Top patents by PatentIndex Score
10 records- 0156US12240905B2Antibodies binding CTLA-4 and uses thereofHARBOUR BIOMED SHANGHAI CO LTD·Filed 2021·Granted Mar 4, 2025·0 cites·20 claims
- 0252US2025215089A1Antigen-binding protein targeting pd-l1 and cd40, preparation therefor, and use thereofHARBOUR BIOMED SHANGHAI CO LTD·Filed 2023·Application pending·0 cites
- 0351US2024010721A1Ror1-targeting antibody or antigen-binding fragment thereof, preparation method therefor, and application thereofHARBOUR BIOMED SHANGHAI CO LTD·Filed 2021·Application pending·0 cites
- 0450US2024269276A1Specific binding protein targeting pd-l1 and cd73HARBOUR BIOMED SHANGHAI CO LTD·Filed 2022·Application pending·0 cites
- 0548US11098122B2Antibodies binding CTLA-4 and uses thereofHARBOUR BIOMED SHANGHAI CO LTD·Filed 2018·Granted Aug 24, 2021·0 cites·17 claims
- 0647US2024270847A1Antibody binding ctla-4 and use thereofHARBOUR BIOMED SHANGHAI CO LTD·Filed 2022·Application pending·0 cites
- 0746US2022411513A1Anti-pd-l1 antigen binding protein and application thereofHARBOUR BIOMED SHANGHAI CO LTD·Filed 2020·Application pending·0 cites
- 0846US2024228635A9Ccr8 antibody and application thereofB7 THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0943US2023242658A14-1bb-binding protein and use thereofNONA BIOSCIENCES SUZHOU CO LTD·Filed 2021·Application pending·0 cites
- 1043US2023357425A1Anti-cd73 antibody and application thereofHARBOUR BIOMED SHANGHAI CO LTD·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Xin Gan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →